Editorial: Diagnostic, prognostic and predictive factors of response in the era of precision oncology in breast cancer
Front Oncol
.
2023 Nov 23:13:1337315.
doi: 10.3389/fonc.2023.1337315.
eCollection 2023.
Authors
Diletta Favero
1
2
,
Daniele Generali
3
4
,
Francesco Schettini
2
5
6
Affiliations
1
Department of Medical Oncology, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
2
Translational Genomics and Targeted Therapies in Solid Tumors Group, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
3
Breast and Brain Unit, ASST Cremona, Cremona, Italy.
4
Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy.
5
Medical Oncology Department, Hospital Clinic of Barcelona, Barcelona, Spain.
6
Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.
PMID:
38074662
PMCID:
PMC10702554
DOI:
10.3389/fonc.2023.1337315
No abstract available
Keywords:
biomarker; breast cancer; precision oncology; prediction; prognosis.
Publication types
Editorial
Grants and funding
The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.